The Alliance for NanoHealth (ANH) was the first multi-disciplinary, multi-institutional collaborative research endeavor aimed solely at using nanotechnology to bridge the gaps between medicine, biology, materials science, computer technology and public policy. The mission of the Alliance is to collectively bridge the disciplines to develop nanotechnology-based solutions to unresolved problems in medicine. Its principal goal is to provide new clinical approaches to saving lives through better diagnosis, treatment, and prevention.
ANH institutions are committed to develop and apply nanotechnology tools in the battle against heart disease, cancer, diabetes, stroke, and infection. The willingness to share strengths among the disciplines with educational and training activities as well as welcoming new scientific associations provides a rich collaborative foundation upon which the ANH has established a wealth of research and development opportunities.
Nanotechnology research in Houston continues to build and one leader in the field wants people to understand this is not a technology for the future ... it is making a difference now. Houston Public Radio's Capella Tucker reports.
S. Ward Casscells, M.D., the John Edward Tyson Distinguished Professor of Medicine and vice president for Biotechnology at the UT Health Science Center has received the 2004 Gen. Maxwell Thurman Award for his work in the use of advanced technologies to improve emergency medical care. The award was announced at the ninth annual meeting of the American Telemedicine Association in Tampa, Florida.
Wah Chiu, PhD, minces no words. He is a problem solver.
His approach to scientific discovery is more like that of a hurdler, who overcomes a series of barriers, than the traditional biologist whose research is driven by hypothesis. The Baylor College of Medicine professor of biochemistry and molecular biology admits it is a method of elucidation that sometimes baffles his biological compatriots.
The death of Richard E. Smalley, known to adoring colleagues and students as Rick, marks the passing of a scientific giant whose gift of nanotechnology will profoundly change the world for the better.
Dr. Mauro Ferrari has been named as the new President for the Alliance for NanoHealth
Recent Research Publications
Jason Sakamoto, Paolo Decuzzi, Francesco Gentile, Stanislav I Rokhlin, Lugen Wang, Bin Xie, and Mauro Ferrari
(2007).
Nanomechanics and Tissue Pathology
In: Biological and Biomedical Nanotechnology, edited by Lee, A.P. and Lee, L.J.. Springer, New York City, pages 461-501.
A J Nijdam, M Ming-Cheng Cheng, D H Geho, R Fedele, P Herrmann, K Killian, V Espina, E F,3rd Petricoin, L A Liotta, and M Ferrari
(2007).
ANH Lunch Series (April 24, 2007): Thioaptamers in Proteomics Diagnostics and Therapeutics for Nanobiodefense
Chief Operating Officer: Jason H. Sakamoto, Ph.D.
Research Publications
Nanotechnology Research is Making a Diffence Now